BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 17525892)

  • 1. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
    Blum W; Porcu P
    Semin Thromb Hemost; 2007 Jun; 33(4):350-4. PubMed ID: 17525892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
    Shafique S; Bona R; Kaplan AA
    Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic apheresis: results from a single center in Turkey.
    Yavasoglu I; Kadikoylu G; Akyol A; Bolaman Z
    Transfus Apher Sci; 2007 Jun; 36(3):249-53. PubMed ID: 17556022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
    Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
    Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
    Aqui N; O'Doherty U
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic hemapheresis.
    Nusbacher J
    Clin Lab Med; 1982 Mar; 2(1):87-106. PubMed ID: 6892261
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
    Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
    Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.
    Linenberger ML; Price TH
    J Intensive Care Med; 2005; 20(2):88-103. PubMed ID: 15855221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications of urgent plasma exchange and cytapheresis therapies--a review based on literature data and personal experience].
    Belák M; Jákó J
    Orv Hetil; 2006 Sep; 147(38):1843-8. PubMed ID: 17066601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG
    Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
    Korkmaz S
    Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis].
    Bubała H; Sońta-Jakimczyk D; Janik-Moszant A; Szczepański T; Tomaszewska R; Drybańska B; Sierantowicz-Zdaniewicz U; Frankiewicz E
    Pol Merkur Lekarski; 2004 Nov; 17(101):500-2. PubMed ID: 15754643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic leukapheresis in a leukostasis syndrome complicating chronic lymphoid leukemia].
    Alcalay D; Deleplanque P; Maubras MA; Guilhot F
    Ann Med Interne (Paris); 1988; 139 Suppl 1():53-4. PubMed ID: 3247994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloproliferative disorders and the hyperviscosity syndrome.
    Adams BD; Baker R; Lopez JA; Spencer S
    Emerg Med Clin North Am; 2009 Aug; 27(3):459-76. PubMed ID: 19646648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheologic studies before and after therapeutic cytapheresis and plasma exchange treatment].
    Waxenberger Y; Schäd S; Gross D; Ullrich H; Hohe R; Langer R; Henrich H; Weibecke D
    Beitr Infusionsther; 1992; 30():301-5. PubMed ID: 1284721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.